The epistatic interaction between the dopamine D3 receptor and dysbindin-1 modulates higher-order cognitive functions in mice and humans

No abstract is available for this paper.

• Publication year

  2019

• Venue

  Molecular Psychiatry

• Publication date

  2019-09-06

• Fields of study

  Biology, Medicine, Psychology

• Identifiers
  DOI 10.1038/s41380-019-0511-4PMID 31492942
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Variations in Dysbindin-1 are associated with cognitive response to antipsychotic drug treatment

  2018influential reference
• Remote memories are enhanced by COMT activity through dysregulation of the endocannabinoid system in the prefrontal cortex

  2018cited by this paper
• Dopamine, the antipsychotic molecule: A perspective on mechanisms underlying antipsychotic response variability

  2018cited by this paper
• Buspirone Counteracts MK-801-Induced Schizophrenia-Like Phenotypes through Dopamine D3 Receptor Blockade

  2017cited by this paper
• The dopamine D3 receptor, a quarter century later

  2017cited by this paper
• Evidence of an Epistatic Effect Between Dysbindin-1 and Neuritin-1 Genes on the Risk for Schizophrenia Spectrum Disorders

  2017cited by this paper
• Dopamine transporter (DAT) genetic hypofunction in mice produces alterations consistent with ADHD but not schizophrenia or bipolar disorder.

  2017cited by this paper
• D3 Receptors Regulate Excitability in a Unique Class of Prefrontal Pyramidal Cells

  2017influential reference
• Pathway-Specific Dopamine Abnormalities in Schizophrenia.

  2017cited by this paper
• First-Generation Antipsychotic Haloperidol Alters the Functionality of the Late Endosomal/Lysosomal Compartment in Vitro

  2016cited by this paper
• Genetic Disruption of Arc/Arg3.1 in Mice Causes Alterations in Dopamine and Neurobehavioral Phenotypes Related to Schizophrenia.

  2016influential reference
• Dysregulation of the dopamine system in the pathophysiology of schizophrenia and depression

  2016cited by this paper
• Dopamine D3 Receptor Antagonists as Potential Therapeutics for the Treatment of Neurological Diseases

  2016cited by this paper
• Dysbindin‐1 modifies signaling and cellular localization of recombinant, human D3 and D2 receptors

  2016cited by this paper
• Current drug treatments targeting dopamine D3 receptor.

  2016cited by this paper
• Pharmacological targeting of dopamine D3 receptors: Possible clinical applications of selective drugs.

  2015cited by this paper
• Sex-dichotomous effects of functional COMT genetic variations on cognitive functions disappear after menopause in both health and schizophrenia.

  2015cited by this paper
• Blonanserin Ameliorates Phencyclidine-Induced Visual-Recognition Memory Deficits: the Complex Mechanism of Blonanserin Action Involving D3-5-HT2A and D1-NMDA Receptors in the mPFC

  2015cited by this paper
• COMT Genetic Reduction Produces Sexually Divergent Effects on Cortical Anatomy and Working Memory in Mice and Humans.

  2015cited by this paper
• The mRNA Expression Status of Dopamine Receptor D2, Dopamine Receptor D3 and DARPP-32 in T Lymphocytes of Patients with Early Psychosis

  2015cited by this paper
• The ultimate intra-/extra-dimensional attentional set-shifting task for mice.

  2014cited by this paper
• Biological Insights From 108 Schizophrenia-Associated Genetic Loci

  2014cited by this paper
• Epistatic interaction between COMT and DTNBP1 modulates prefrontal function in mice and in humans

  2014influential reference
• Update: studies of prepulse inhibition of startle, with particular relevance to the pathophysiology or treatment of Tourette Syndrome.

  2013cited by this paper
• The potential role of dopamine D₃ receptor neurotransmission in cognition.

  2013cited by this paper
• Chronic and Acute Intranasal Oxytocin Produce Divergent Social Effects in Mice

  2013cited by this paper
• Mouse models of genetic effects on cognition: relevance to schizophrenia.

  2012cited by this paper
• Hypothesis review: are clathrin-mediated endocytosis and clathrin-dependent membrane and protein trafficking core pathophysiological processes in schizophrenia and bipolar disorder?

  2012cited by this paper
• Use-dependent inhibition of synaptic transmission by the secretion of intravesicularly accumulated antipsychotic drugs.

  2012cited by this paper
• Psychiatric drugs bind to classical targets within early exocytotic pathways: therapeutic effects.

  2012cited by this paper
• Use-Dependent Inhibition of Synaptic Transmission by the Secretion of Intravesicularly Accumulated Antipsychotic Drugs

  2012cited by this paper
• Synaptic Activity Unmasks Dopamine D2 Receptor Modulation of a Specific Class of Layer V Pyramidal Neurons in Prefrontal Cortex

  2012cited by this paper
• Dysbindin-1 modulates prefrontal cortical activity and schizophrenia-like behaviors via dopamine/D2 pathways

  2012influential reference
• The role of dopamine D(3) receptors in antipsychotic activity and cognitive functions.

  2012cited by this paper
• Dopamine D3 Receptors Are Down-regulated following Heterologous Endocytosis by a Specific Interaction with G Protein-coupled Receptor-associated Sorting Protein-1*

  2010cited by this paper
• Modeling the positive symptoms of schizophrenia in genetically modified mice: pharmacology and methodology aspects.

  2010cited by this paper
• Modeling the Positive Symptoms of Schizophrenia in Genetically Modified Mice: Pharmacology and Methodology Aspects

  2010cited by this paper
• Projection-Specific Neuromodulation of Medial Prefrontal Cortex Neurons

  2010cited by this paper
• Role of dysbindin in dopamine receptor trafficking and cortical GABA function

  2009influential reference
• Dysbindin-1 and Its Protein Family

  2009cited by this paper
• Effects of typical and atypical antipsychotic drugs on gene expression profiles in the liver of schizophrenia subjects

  2009cited by this paper
• Habituation and sensitization of acoustic startle: opposite influences of dopamine D1 and D2-family receptors.

  2009cited by this paper
• Set-shifting ability and schizophrenia: a marker of clinical illness or an intermediate phenotype?

  2008cited by this paper
• On the historical and conceptual background of the Wisconsin Card Sorting Test.

  2008cited by this paper
• Genetic Dissection of the Role of Catechol-O-Methyltransferase in Cognition and Stress Reactivity in Mice

  2008cited by this paper
• Antipsychotics differ in their ability to internalise human dopamine D2S and human serotonin 5-HT1A receptors in HEK293 cells.

  2008cited by this paper
• Inverted-U dopamine D1 receptor actions on prefrontal neurons engaged in working memory

  2007cited by this paper
• Accumbal dopamine D2 receptors are important for sensorimotor gating in C3H mice

  2007cited by this paper
• Tbx1 haploinsufficiency is linked to behavioral disorders in mice and humans: Implications for 22q11 deletion syndrome

  2006cited by this paper
• A functional variant of the dopamine D3 receptor is associated with risk and age-at-onset of essential tremor.

  2006cited by this paper
• Startle gating deficits in a large cohort of patients with schizophrenia: relationship to medications, symptoms, neurocognition, and level of function.

  2006cited by this paper
• Transient and selective overexpression of dopamine D2 receptors in the striatum causes persistent abnormalities in prefrontal cortex functioning.

  2006cited by this paper
• Effectiveness of antipsychotic drugs in patients with chronic schizophrenia.

  2005cited by this paper
• Dopamine responsiveness is regulated by targeted sorting of D2 receptors.

  2005cited by this paper
• Mice lacking dopamine D2 and D3 receptors exhibit differential activation of prefrontal cortical neurons during tasks requiring attention.

  2005cited by this paper
• Dopamine D3 receptor antagonists as therapeutic agents.

  2005cited by this paper
• Genes, dopamine and cortical signal-to-noise ratio in schizophrenia.

  2004cited by this paper
• Factors governing prepulse inhibition and prepulse facilitation of the acoustic startle response in mice.

  2004cited by this paper
• The National Institute of Mental Health Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) project: schizophrenia trial design and protocol development.

  2003cited by this paper
• Neurocognitive assessment in the Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) project schizophrenia trial: development, methodology, and rationale.

  2003influential reference
• Human studies of prepulse inhibition of startle: normal subjects, patient groups, and pharmacological studies

  2001cited by this paper
• Cognitive impairment in schizophrenia is the core of the disorder.

  2000cited by this paper
• Layer V neurons bear the majority of mRNAs encoding the five distinct dopamine receptor subtypes in the primate prefrontal cortex

  1998cited by this paper
• Mesolimbic dopamine D3 receptors and use of antipsychotics in patients with schizophrenia. A postmortem study.

  1997cited by this paper
• A targeted mutation of the D3 dopamine receptor gene is associated with hyperactivity in mice.

  1996cited by this paper
• Electron microscopic study on schizophrenia

  1972cited by this paper
• ysbindin and Schizophrenia : It ’ s Dopamine and lutamate All Over Again

  year unknowncited by this paper

• Blockade of dopamine D3 receptors improves hippocampal synaptic function and rescues age‐related cognitive phenotype

  2024cites this paper
• Dysbindin-1 Mutation Alters Prefrontal Cortex Extracellular Glutamate and Dopamine In Vivo

  2024influential citation
• Sex dimorphism controls dysbindin-related cognitive dysfunctions in mice and humans with the contribution of COMT

  2024cites this paper
• Loss of dysbindin-1 in excitatory neurons in mice impacts NMDAR-dependent behaviors, neuronal morphology and synaptic transmission in the ventral hippocampus

  2024cites this paper
• The Role of Dopamine D3 Receptors, Dysbindin, and Their Functional Interaction in the Expression of Key Genes for Neuroplasticity and Neuroinflammation in the Mouse Brain

  2023cites this paper
• Canonical and Non-Canonical Antipsychotics’ Dopamine-Related Mechanisms of Present and Next Generation Molecules: A Systematic Review on Translational Highlights for Treatment Response and Treatment-Resistant Schizophrenia

  2023cites this paper
• Dopaminergic signalling and behavioural alterations by Comt–Dtnbp1 genetic interaction and their clinical relevance

  2023influential citation
• Dopamine D3 Receptor, Cognition and Cognitive Dysfunctions in Neuropsychiatric Disorders: From the Bench to the Bedside.

  2022cites this paper
• Imputed expression of schizophrenia‐associated genes and cognitive measures in patients with schizophrenia

  2022cites this paper
• Clozapine's multiple cellular mechanisms: What do we know after more than fifty years? A systematic review and critical assessment of translational mechanisms relevant for innovative strategies in treatment-resistant schizophrenia.

  2022cites this paper
• Collagen VI deficiency causes behavioral abnormalities and cortical dopaminergic dysfunction

  2022cites this paper
• Identification of risk genes for Alzheimer’s disease by gene embedding

  2022cites this paper
• Dysbindin-1A modulation of astrocytic dopamine and basal ganglia dependent behaviors relevant to schizophrenia

  2022influential citation
• Gut microbiota alterations promote traumatic stress susceptibility associated with p-cresol-induced dopaminergic dysfunctions.

  2022cites this paper
• Long-lasting rescue of schizophrenia-relevant cognitive impairments via risperidone-loaded microPlates

  2022cites this paper
• Codoping g-C3N4 with boron and graphene quantum dots: Enhancement of charge transfer for ultrasensitive and selective photoelectrochemical detection of dopamine.

  2022cites this paper
• Probing the Skin–Brain Axis: New Vistas Using Mouse Models

  2022cites this paper
• Decision tree classification of cognitive functions with D2 receptor occupancy and illness severity in late-life schizophrenia.

  2022cites this paper
• PharmacoSTORM nanoscale pharmacology reveals cariprazine binding on Islands of Calleja granule cells

  2021cites this paper
• Neuronal Dopamine D3 Receptors: Translational Implications for Preclinical Research and CNS Disorders

  2021cites this paper
• Pharmacotherapy of schizophrenia: Mechanisms of antipsychotic accumulation, therapeutic action and failure.

  2021cites this paper
• Pharmacological and Genetic Evidence of Dopamine Receptor 3-Mediated Vasoconstriction in Isolated Mouse Aorta

  2021cites this paper
• Atypical Antipsychotics and Metabolic Syndrome: From Molecular Mechanisms to Clinical Differences

  2021cites this paper
• Astrocytic Regulation of Basal Ganglia Dopamine/D2-Dependent Behaviors

  2021cites this paper
• Sex, Pramipexole and Tiagabine Affect Behavioral and Hormonal Response to Traumatic Stress in a Mouse Model of PTSD

  2021cites this paper
• Automatic Intra-/Extra-Dimensional Attentional Set-Shifting Task in Adolescent Mice

  2021cites this paper
• Social behavior in 16p11.2 and 22q11.2 copy number variations: Insights from mice and humans

  2021cites this paper
• The Role of Dopaminergic Genes in Probabilistic Reinforcement Learning in Schizophrenia Spectrum Disorders

  2021cites this paper
• Developmental Genes and Regulatory Proteins, Domains of Cognitive Impairment in Schizophrenia Spectrum Psychosis and Implications for Antipsychotic Drug Discovery: The Example of Dysbindin-1 Isoforms and Beyond

  2020cites this paper
• A novel arousal-based individual screening reveals susceptibility and resilience to PTSD-like phenotypes in mice

  2020cites this paper
• Key Clinical Interest Outcomes of Pharmaceutical Administration for Veterans With Post-Traumatic Stress Disorder Based on Pooled Evidences of 36 Randomised Controlled Trials With 2,331 Adults

  2020cites this paper
• Pharmacogenomic Biomarkers and Their Applications in Psychiatry

  2020cites this paper
• Dopamine, Cognitive Impairments and Second-Generation Antipsychotics: From Mechanistic Advances to More Personalized Treatments

  2020cites this paper
• The Discrete Paired-trial Variable-delay T-maze Task to Assess Working Memory in Mice.

  2020cites this paper
• The Role of Zebrafish and Laboratory Rodents in Schizophrenia Research

  2020cites this paper
• Dopamine Receptor Subtypes, Physiology and Pharmacology: New Ligands and Concepts in Schizophrenia

  2020cites this paper
• Dual-acting agents for improving cognition and real-world function in Alzheimer's disease: Focus on 5-HT6 and D3 receptors as hubs.

  2020cites this paper
• Translational genomics and beyond in bipolar disorder

  2020cites this paper
• Retinal biomarkers and pharmacological targets for Hermansky-Pudlak syndrome 7

  2020cites this paper
• Cognition- and circuit-based dysfunction in a mouse model of 22q11.2 microdeletion syndrome: effects of stress

  2020cites this paper
• Polygenic Risk Scores Shed Light on the Relationship between Schizophrenia and Cognitive Functioning: Review and Meta-Analysis

  2020influential citation